Antiarrhythmic Drug Cibenzoline Attenuates Left Ventricular Pressure Gradient and Improves Transmitral Doppler Flow Pattern in Patients With Hypertrophic Obstructive Cardiomyopathy Caused by Midventricular Obstruction-Reference-Cited by-同舟云学术

Antiarrhythmic Drug Cibenzoline Attenuates Left Ventricular Pressure Gradient and Improves Transmitral Doppler Flow Pattern in Patients With Hypertrophic Obstructive Cardiomyopathy Caused by Midventricular Obstruction

Published:2005 Issue:8 Volume:69 Page:940-945
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hamada Mareomi¹,Shigematsu Yuji²,Inaba Shinji¹,Aono Jun¹,Ikeda Shuntaro¹,Watanabe Kouki¹,Ogimoto Akiyoshi²,Ohtsuka Tomoaki²,Hara Yuji²,Higaki Jitsuo²

Affiliation:

1. Division of Cardiology, Uwajima City Hospital

2. The Second Department of Internal Medicine, Ehime University School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/69/8/69_8_940/_pdf

Reference28 articles.

1. Mid-ventricular obstruction: A variant of obstructive cardiomyopathy

2. Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort

3. Diagnostic Usefulness of Carotid Pulse Tracing in Patients With Hypertrophic Obstructive Cardiomyopathy Due to Midventricular Obstruction

4. Pacing in Distal Left Ventricular Hypertrophic Cardiomyopathy

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ECG simulation of cardiac hypertrophic condition;Cardiovascular and Respiratory Bioengineering;2022

2. Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy;ESC Heart Failure;2021-10-29

3. Mid‐ventricular obstruction is associated with non‐sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy;Clinical Cardiology;2021-02-24

4. Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Under Extracorporeal Membrane Oxygenation Support;JACC: Case Reports;2020-10

5. Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy;Internal Medicine;2019-02-15